314240-82-9

Basic information

• Product Name: 1H-IMidazole, 2-(3-broMophenyl)-4,5-dihydro-
• Synonyms: 1H-IMidazole, 2-(3-broMophenyl)-4,5-dihydro-;2-(3-bromophenyl)-4,5-dihydro-1H-Imidazole
• CAS NO: 314240-82-9
• Molecular Formula: C9H9BrN2
• Molecular Weight: 225.08516
• Mol File: 314240-82-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-IMidazole, 2-(3-broMophenyl)-4,5-dihydro-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-IMidazole, 2-(3-broMophenyl)-4,5-dihydro-(314240-82-9)
• EPA Substance Registry System: 1H-IMidazole, 2-(3-broMophenyl)-4,5-dihydro-(314240-82-9)

Safety Data

• Hazardous Substances Data: 314240-82-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
1H-Imidazole, 2-(3-bromophenyl)-4,5-dihydrois used as a key intermediate in the synthesis of various pharmaceuticals for its unique structural and reactivity features, contributing to the development of new drugs with improved therapeutic properties.
Used in Agrochemical Synthesis:
In the agrochemical industry, 1H-Imidazole, 2-(3-bromophenyl)-4,5-dihydroserves as a crucial building block in the creation of novel agrochemicals, enhancing crop protection and management strategies through its incorporation into effective and targeted compounds.
Used in Research and Development:
1H-Imidazole, 2-(3-bromophenyl)-4,5-dihydrois utilized in research and development settings to explore its potential biological and pharmacological activities. This exploration aids in uncovering new avenues for drug discovery and understanding the compound's interactions with biological systems.

Upstream product

• 6952-59-6 3-cyanobromobenzene 
• 107-15-3 ethylenediamine 
• 3132-99-8 m-bromobenzoic aldehyde 

Downstream Products

• 1621586-76-2 4-(2-(3-bromophenyl)-4,5-dihydroimidazol-1-yl)benzenesulfonamide 
• 1621587-06-1 2-(3-bromophenyl)-1-(4-(methylsulfonyl)phenyl)-4,5-dihydro-1H-imidazole 
• 1441932-64-4 C₁₆H₁₃BrN₄ 
• 1441930-51-3 C₁₆H₁₁BrN₄O₂ 

Relevant articles and documents

Visible Light-Promoted Aryl Azoline Formation over Mesoporous Organosilica as Heterogeneous Photocatalyst

N-heterocyclic compounds demonstrate wide applications ranging from natural compound production to coordination chemistry. Usually, the synthesis of N-heterocyclic compounds is conducted under thermal conditions, mostly by Lewis acids or metal-containing compounds as molecular catalysts. Here, we report a photocatalytic route for aryl azoline formation by mesoporous organosilica as visible light-active and heterogeneous photocatalyst. Via formation of aromatic aldehydes with various amines, 2-phenyl-2-imidazoline, 2-phenyl-2-oxazoline, 2-phenyl-2-thiazoline and their derivatives could be formed with high conversion and selectivity. Additionally, the organosilica photocatalyst showed high stability and reusability.

ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

The present invention relates to a compound of formula (I): wherein: X2 represents a –CO-NRk- group, a -NR'k-CO- group, a -O- group, a -CO- group, a -SO2-group, a -CS-NH- group, a -CH2-NH-, a group, or a heterocyclyl, wherein the heterocyclyl is a 5- or 6-membered ring comprising 1, 2, 3 or 4 heteroatoms selected from O, S and/or N; Y2 represents a hydrogen atom, a halogen atom, a hydroxyl group, a morpholinyl group, optionally substituted by a (C1-C4)alkylgroup or a trifluoromethyl group, a bridged morpholinyl group, a (C5-C11)bicycloalkyl group, an adamantyl group, a piperidinyl group, a (C1-C4)alkenyl group, a -PO(ORa)(ORb) group, a 5-membered heteroaromatic ring or a –CR1R2R3 group, or any of its pharmaceutically acceptable salt. The present invention further relates to new compounds, to pharmaceutical compositions containing them and to synthesis process for manufacturing them.

Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases

A series of novel benzene sulfonamides (previously evaluated as selective cyclooxygenase-2 inhibitors) has been profiled against human carbonic anhydrases I, II, IV and VII in an attempt to observe the manifestation of the well established “tail” approach

Antibacterial drug leads: DNA and enzyme multitargeting

We report the results of an investigation of the activity of a series of amidine and bisamidine compounds against Staphylococcus aureus and Escherichia coli. The most active compounds bound to an AT-rich DNA dodecamer (CGCGAATTCGCG)2 and using DSC were found to increase the melting transition by up to 24 °C. Several compounds also inhibited undecaprenyl diphosphate synthase (UPPS) with IC50 values of 100-500 nM, and we found good correlations (R2 = 0.89, S. aureus; R2 = 0.79, E. coli) between experimental and predicted cell growth inhibition by using DNA δTm and UPPS IC50 experimental results together with one computed descriptor. We also solved the structures of three bisamidines binding to DNA as well as three UPPS structures. Overall, the results are of general interest in the context of the development of resistance-resistant antibiotics that involve multitargeting.

A convenient synthesis of oxazolines and imidazolines from aromatic aldehydes with pyridinium hydrobromide perbromide in water

Various 2-oxazolines were prepared from aromatic aldehydes and 2-aminoethanol with pyridinium hydrobromide perbromide in water at room temperature. 2-Imidazolines were also obtained in good yields from aromatic aldehydes and ethylenediamine under the same reaction conditions. Georg Thieme Verlag Stuttgart.

BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS

The invention relates to novel heterocycles of formula (I), processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.